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a b s t r a c t
The paramyxovirus family has a genome consisting of a single strand of negative sense RNA. This
genome acts as a template for two distinct processes: transcription to generate subgenomic, capped and
polyadenylated mRNAs, and genome replication. These viruses only encode one polymerase. Thus, an
intriguing question is, how does the viral polymerase initiate and become committed to either
transcription or replication? By answering this we can begin to understand how these two processes
are regulated. In this review article, we present recent ﬁndings from studies on the paramyxovirus,
respiratory syncytial virus, which show how its polymerase is able to initiate transcription and
replication from a single promoter. We discuss how these ﬁndings apply to other paramyxoviruses.
Then, we examine how trans-acting proteins and promoter secondary structure might serve to regulate
transcription and replication during different phases of the paramyxovirus replication cycle.
& 2015 Elsevier Inc. All rights reserved.
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Introduction
The family Paramyxoviridae is large and diverse. It encompasses
viruses that infect reptilian, avian and mammalian hosts, and
includes a number of human pathogens, such as respiratory syncytial
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virus (RSV), mumps (MuV), measles (MeV), parainﬂuenza viruses
(PIV 1–5), and the newly emerged Nipah and Hendra viruses. The
family is divided into two subfamilies, the Pneumovirinae and
Paramyxovirinae, which contain two and seven genera, respectively
(King et al., 2012). The paramyxoviruses have a single stranded,
negative sense RNA genome, and so are members of the non-
segmented, negative sense (NNS) RNA virus order. The paramyxo-
viruses also share a similar (although not identical) cohort of genes as
each other. During their replication cycle, the viral genome is
transcribed to produce subgenomic, capped and polyadenylated
mRNAs and replicated to produce encapsidated antigenome and
genome RNAs (Lamb and Parks, 2007). Despite the fact that
approximately two-thirds of the paramyxovirus genome encodes
proteins involved in performing and regulating gene expression and
genome replication, paramyxoviruses only encode one polymerase.
This raises questions that have puzzled researchers for more than
three decades, namely how does the polymerase become committed
to either mRNA transcription or genome replication, and how can
these processes be differentially regulated? In this review, we
attempt to address these questions. The review is divided into three
parts. Part 1 presents an overview of paramyxovirus transcription
and replication and discusses previously proposed models. In Part 2,
we describe relatively new ﬁndings regarding RSV transcription and
replication, propose a revised model that ﬁts these data, and discuss
if this revised model can be applied across the paramyxovirus family.
With models to describe possible mechanisms of transcription and
replication initiation, it is possible to consider how these processes
might be regulated during infection and in Part 3 we describe
information available regarding regulation of transcription and
replication, highlighting similarities and differences across the family.
Part 1: paramyxovirus transcription and replication
Overview of paramyxovirus transcription and replication
The general strategy of paramyxovirus transcription and repli-
cation is similar to that of other NNS RNA viruses (Lamb and Parks,
2007; Whelan et al., 2004) and much of what we know has been
as a result of studies on another virus in the order, vesicular
stomatitis virus (VSV), a member of the family Rhabdoviridae.
However, there is a considerable body of research on paramyx-
oviruses, as reviewed previously (Lamb and Parks, 2007), and this
is described below.
The core polymerase is a complex of two proteins, the large
polymerase subunit L, which contains the enzymatic domains
involved in RNA synthesis, capping and cap methylation, and the
phosphoprotein, P, which is an essential cofactor (Morin et al., 2013;
Horikami et al., 1992; Noton et al., 2012; Mazumder et al., 1994). The
polymerase executes transcription and replication by recognizing
and responding to a number of essential cis-acting elements within
the virus genome (Fig. 1). At the beginning and end of each gene are
short (10–13 nt) conserved signals termed gene start (gs) and gene
end (ge) signals, respectively, and between each gene is a short, non-
transcribed intergenic region. At the 30 end of the genome, before the
ﬁrst gene, is a leader (le) promoter region, which is 40–55 nt long,
and at the 50 end is a trailer region which is variable in length,
depending on the virus (Lamb and Parks, 2007). An important
feature of the genome template is that it is associated along its
length with an interlinking polymer of nucleoprotein (N) to form a
helical nucleocapsid, such that cis-acting RNA elements are buried
within the N-RNA structure (Cox et al., 2014; Ruigrok et al., 2011;
Tawar et al., 2009). Most likely for this reason, when the polymerase
transcribes the genome to produce mRNAs, it cannot access indivi-
dual genes independently. Instead, it ﬁrst engages the template at or
near the 30 end of the genome, within the le promoter. The
polymerase then moves along the genome, presumably with the N
subunits of the nucleocapsid being displaced and replaced as the
polymerase passes by. As the polymerase proceeds, it responds to the
gs and ge signals it encounters to generate the subgenomic mRNAs:
at a gs signal, the polymerase initiates mRNA synthesis (opposite the
ﬁrst nucleotide of the gs) and at the ge signal, it releases the RNA
(Lamb and Parks, 2007). The polymerase can then scan the intergenic
region to locate the next gs signal and begin mRNA synthesis of the
next gene (Fearns and Collins, 1999). This allows the polymerase to
generate subgenomic RNAs. The mRNAs are also modiﬁed to contain
a 50 methyl cap and 30 poly A tail. Work with VSV and the
paramyxovirus, Sendai virus (SeV) indicates that the complement
of the gs signal, which lies at the 50 end of the mRNA, contains a
signal that directs the capping reaction and methylation of the cap
(Ogino et al., 2005; Wang et al., 2007; Stillman and Whitt, 1999). The
ge signal contains a poly U tract, and it is thought that stuttering of
the polymerase on this U-stretch leads to polyadenylation of the
mRNA (Whelan et al., 2004). Similarly to cellular capping, there is
evidence that addition of the cap is important to allow the
transcribing polymerase to transition into an elongation mode: in
the case of RSV, if capping is inhibited, the polymerase aborts RNA
synthesis approximately 45–50 nt after initiating at the gs signal
(Liuzzi et al., 2005).
To replicate the genome, the polymerase also initiates RNA
synthesis at the le promoter. In this case, it must initiate precisely
opposite the ﬁrst nucleotide of the template. During replication, the
polymerase does not respond to the gene junction signals, but instead
elongates the nascent RNA along the complete length of the genome
to produce a positive sense antigenome. The 30 end of the antigenome
contains the complement of the trailer, referred to here as tr
genome (-) 
antigenome (+) 
mRNA 
le 
tr
A 
A 
A A 
A 
A 
transcription 
replication 
replication 
Fig. 1. Schematic diagram illustrating a representative paramyxovirus genome and transcription and RNA replication products. The genes are represented by purple boxes,
and gs and ge signals are illustrated with white and black boxes, respectively. The le and tr promoters at the 30 ends of the genome and antigenome, respectively, are
indicated with green arrows. The genome acts as a template for mRNA and antigenome synthesis, and the antigenome as a template for genome RNA synthesis. The mRNA
caps are indicated with black circles. The antigenome is shown covered with gray ovals, representing N protein, to indicate that it is encapsidated. The genome is also
encapsidated, but this is not shown so that the cis-acting signals can be clearly seen.
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promoter. The tr promoter in turn signals the polymerase to initiate
and perform genome RNA synthesis. The antigenome and genome
RNAs are not capped, but instead are encapsidated with N protein,
which is delivered to the elongating RNA in a complex with P (N0P,
where N0 is a monomer of N) (Horikami et al., 1992). It is thought that
concurrent encapsidation causes the polymerase to enter a super-
processive mode, allowing it to disregard the ge signals and extend to
the end of the template (Vidal and Kolakofsky, 1989; Gubbay et al.,
2001; McGivern et al., 2005). Encapsidation initiation appears to be
dependent on cis-acting elements in the le and tr promoters
(McGivern et al., 2005). These elements could function in the context
of the promoter within the template strand, to recruit a speciﬁc pool
of polymerase that is capable of delivering N protein onto the RNA
that it is synthesizing. Alternatively, they could function at the 50 end
of the nascent RNA product to signal an initial nucleation event that
begins polymerization of N protein onto the growing RNA chain.
What emerges from this description of transcription and
replication is that the le and tr promoters and the gs signals are
all multifunctional entities, which are not only important for
directing initiation of RNA synthesis, but also directing modiﬁca-
tion of the RNA products. These modiﬁcations enable the poly-
merase to elongate the RNA and also serve to protect the RNA from
nucleases. This multifunctional nature of the cis-acting signals
complicates analysis of the initial events in RNA synthesis, parti-
cularly in cell-based assays in which abortive (i.e. prematurely
released), unmodiﬁed RNAs might be unstable, and this is the
reason why understanding mechanisms underlying transcription
and replication initiation and regulation has proven difﬁcult.
NNS RNA virus transcription and replication initiation models
A complexity in understanding mechanisms by which the poly-
merase is coordinated between transcription and RNA replication is
that it is difﬁcult to conclusively deﬁne where transcription begins on
the viral genome. The mRNA for the ﬁrst protein-coding gene is
initiated at the ﬁrst gs signal (at nt 40–55), but how the polymerase
accesses this signal has been the focus of debate (Curran and
Kolakofsky, 2008; Whelan, 2008; Banerjee, 2008). Three models have
been proposed to explain how this could happen, based largely on
studies with paramyxoviruses (mainly SeV, PIV-3 and RSV) and VSV.
Model 1: according to this model, transcription and replication are
both initiated in exactly the same way, opposite the ﬁrst nucleotide of
the le promoter (Vidal and Kolakofsky, 1989; Kolakofsky et al., 2004).
In its simplest version, this model postulates that a single pool of
polymerase can initiate both processes. The polymerase begins
transcription by ﬁrst synthesizing an RNA transcript complementary
to the le region (leþ). At or near the end of the le, this RNA is released
and the polymerase is able to scan the template to locate the ﬁrst gs
signal and reinitiate RNA synthesis. It is then committed to mRNA
transcription. Replication would occur when N protein accumulates to
a sufﬁciently high concentration to initiate encapsidation very quickly
after initiation of leþ synthesis. If the leþ RNA becomes encapsidated
before being released, this stabilizes the polymerase-template-nascent
RNA complex and commits the polymerase to replication. As described
in detail in later sections, this model is the most consistent with what
is known regarding paramyxoviruses.
Model 2: the second model proposes that there are two pools of
polymerase, a transcriptase and a replicase that consists of L-P in
complex with different proteins (Whelan, 2008; Banerjee, 2008;
Qanungo et al., 2004). According to this model, the replicase initiates
at the 30 end of the genome, whereas the transcriptase initiates
directly at the ﬁrst gs signal and then proceeds to synthesize capped
and polyadenylated mRNAs. This model is consistent with results
from a number of studies with the rhabdovirus VSV (Keene et al.,
1981; Whelan and Wertz, 1999, 2002; Qanungo et al., 2004).
Model 3: ﬁnally, a universal model has been proposed which
attempts to tie together the two models described above (Curran and
Kolakofsky, 2008). This model postulates that N0P is required for RNA
synthesis initiation from position 1 of the template, to aid initiation
from the 30 end of the linear genome. According to this model, when
the virus ﬁrst enters the cell, when N0P would not be present, the
polymerase cannot initiate at the 30 end, and instead relies on cellular
factors to help the polymerase access the ﬁrst gs signal to begin
transcription. However, once N0P has been synthesized, the poly-
merase instead switches to initiating at the 30 end. When N0P is
present at a low level, the polymerase synthesizes a leþ RNA, but
because this is not encapsidated, the polymerase aborts RNA synth-
esis and reinitiates mRNA synthesis at the gs signal. At high levels of
N0P, the leþ transcript becomes encapsidated and the polymerase is
committed to encapsidation. This model is supported by the ﬁnding
that in an in vitro SeV experiment, low concentrations of N0P
enhanced transcription, whereas high concentrations caused a shift
from transcription to replication. It is also based on results from VSV
UV mapping experiments, which suggest that a cellular factor might
enable transcription initiation at the gs signal in infected cells
(Whelan and Wertz, 2002). However, arguments have been made
against this model (Whelan, 2008; Banerjee, 2008) and more recent
studies with VSV and RSV have shown that the polymerase can
initiate opposite nucleotide 1 of the template independently of N0P
(Noton et al., 2012; Morin et al., 2012).
One problem with trying to develop a universal transcription/
replication model to explain all the data available for VSV and the
paramyxoviruses is that there are differences between the viruses
and they might not utilize a common mechanism. One difference
that is of particular signiﬁcance is that the organization of transcrip-
tion signals in the le promoter is different in the paramyxoviruses
than in VSV, with the paramyxovirus transcription signals being
relatively circumscribed (as described below) and the VSV transcrip-
tion signals existing throughout almost all of le (Whelan and Wertz,
1999; Li and Pattnaik, 1999) (Fig. 2). This distinction could reﬂect the
presence of a 30 terminal transcription start site on the paramyx-
ovirus promoter versus an internal start site on the VSV promoter.
gs  langis 
le ( 44 nt) 
12 36 
gs  langis 
le ( 50 nt) 
24 47 
RSV 
VSV 
Fig. 2. Schematic diagrams of the le and gs regions of RSV (a paramyxovirus) and
VSV (a rhabdovirus) showing the positions of the transcription-speciﬁc signals in the
respective viruses. Regions inwhich mutations reduced transcription to less than 15%
of wt levels are shown in red. Regions in which mutations reduced transcription to
15–40% of wt levels are shown in orange. Substitution of the region shown in gray
had no effect on transcription. The numbers underneath indicate nucleotide
positions. It should be noted that not all signals have been mapped precisely.
CGCUUUUUUACGC . 
CCCUGUUUUA . 
le 
L gs
+1 - replication 
+3 - transcription 
Fig. 3. Diagram showing the alignment of the RSV le and L gs sequences. The ﬁgure
shows the 30 terminal 15 nt of the le and the ﬁrst 10 nt of the L gene. The nucleotides
shown in red in the le region were shown to be essential for both transcription and
replication. These nucleotides align with the L gs signal. The green arrows show the
experimentally determined initiation sites at positions 1 and 3 of le, which we
propose are the replication and transcription initiation sites, respectively.
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Part 2: a revised model for paramyxovirus transcription and
replication initiation
If the data regarding VSV are put aside, model 1, described
above, is highly consistent with almost all available data regarding
the paramyxoviruses. However, based on our recent studies with
RSV we propose a slightly revised version of this model, which is
extremely simple and is supported with experiments performed
in vitro, using a minigenome system and analyzing RNA from RSV
infected cells. This model is also consistent with what is known
about mechanisms of RNA synthesis initiation by RNA dependent
RNA polymerases of other RNA viruses.
Organization of the RSV le promoter
The RSV le region is 44 nt in length and is followed by a 10 nt gs
signal for the ﬁrst gene (Collins et al., 2013). Mutation analysis of
the RSV le region, using a minigenome system, has shown it can be
divided into three segments. The 30 terminal 12 nt are required
for both transcription and RNA replication, nucleotides 13 to 36
are not required for transcription, but are required for replication,
and a U-rich region at the end of le, nucleotides 37–44, increases
transcription efﬁciency, but is not essential for transcription; this
region has no effect on replication (McGivern et al., 2005). The ﬁrst
13 nt were shown to be sufﬁcient to signal RNA synthesis
initiation, indicating this region contains the core promoter
(Cowton and Fearns, 2005; Tremaglio et al., 2013). This core
promoter is capable of recruiting both transcription- and
replication-competent polymerase, suggesting that it either
recruits a single pool of polymerase that subsequently becomes
differentiated, or has the capability to recruit both transcriptase
and replicase forms of polymerase (Cowton and Fearns, 2005).
Nucleotides located at positions 3, 5, 8, 9, 10 and 11 of the le region
are of particular signiﬁcance: if any of these nucleotides were
mutated, both transcription and RNA replication were completely,
or almost completely abrogated (Fearns et al., 2002). Thus, the 30
end of the RSV le region contains a core promoter necessary for
signaling transcription and replication initiation (Fig. 3).
Transcription initiation in RSV
A hint as to how transcription is initiated came serendipitously
from minigenome studies examining how the RSV polymerase is
able to initiate antigenome synthesis opposite nt 1 of the le
(described in more detail below). In these studies, it was noticed
that some RNA appeared to be initiated at position 3 of the le
promoter, in addition to the expected initiation site at position 1
(Noton and Fearns, 2011). Primer extension analysis of RNA
isolated from RSV infected cells conﬁrmed this ﬁnding, clearly
showing that RNA is initiated from both position 1 and 3 sites in
the le promoter. Indeed in infected cells, RNA initiated from
position 3 was signiﬁcantly more abundant than RNA initiated
from position 1, suggesting that initiation from position 3 is the
dominant initiation event (Tremaglio et al., 2013). Inspection of
the le core promoter sequence showed that it bears very strong
resemblance to one of the RSV gs sequences, with the essential
nucleotides from positions 3–11 of le aligning perfectly (Fig. 3).
These ﬁndings suggest that nt 3–11 of the le promoter element
function similarly to a gs signal and position the polymerase to
initiate opposite position 3. Further analysis of the RNAs generated
from the position 1 and 3 initiation sites indicated that the RNA
initiated from position 1 was elongated relatively efﬁciently,
consistent with it being a replication product, as expected. In
contrast, RNA initiated from position 3 was short and heteroge-
neous in length, with the majority of transcripts varying from
approximately 20–25 nucleotides long (Tremaglio et al., 2013).
Why these transcripts were released after such a short distance,
whereas mRNA transcripts are elongated, is not completely clear.
These ﬁndings suggest a very simple and logical model for
transcription initiation, illustrated in Fig. 4A. According to this
model, the polymerase interacts with nucleotides 3–11 of the le
region. This core promoter positions the polymerase so that its
active site is opposite nucleotide 3, similarly to the way in which a
gs signal positions the polymerase to reinitiate mRNA synthesis at a
gene junction. The polymerase initiates RNA synthesis at position 3,
but is unable to enter a stable elongation mode and releases the
RNA after approximately 25 nucleotides. Synthesis of this abortive
leþ RNA allows the polymerase to break contacts with the
promoter. Having released the abortive RNA, the polymerase can
G 
de novo initiation from +3 
reinitiation at the gs signal 
gs
gs
CGCUUUUUU 
G 
CGCUUUUUU 
CGCUUUUUU G 
pol 
le+ transcript 
primer mediated initiation to 
yield RNA from position 1 
gs
gs
CGCUUUUUU 
AC 
CGCUUUUUU 
CGCUUUUUU 
pol 
AC 
AC 
N 
N encapsidation and elongation 
Fig. 4. Diagrams showing the models for initiation of transcription (A) and replication (B) in RSV infection. The ﬁgure shows the relationship between the polymerase, NTPs,
the le promoter region and gs signal in each case. The le region is shown as three sections, reﬂecting the distribution of cis-acting signals, as determined by mapping analysis.
The ﬁrst 11 nucleotides of the le region are written, with the core promoter element shown in red type. The black line in the middle of le indicates sequence required
speciﬁcally for replication, and the white box at the end of le indicates a U-rich sequence that enhances transcription. The gs signal is shown as a large white box. In the
replication initiation model (B), N protein binding to the nascent leþ RNA allows encapsidation. N is likely delivered to the RNA as a soluble N0P complex, but the P protein is
not shown for simplicity.
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scan the template (as it does at the gene junctions) and locate the gs
signal of the ﬁrst gene, aided by the U-rich region at the end of le.
Here it can reinitiate RNA synthesis, extend the RNA beyond 25
nucleotides, and cap the 50 end. This commits the polymerase to
transcription.
Replication initiation in RSV
While the results described above provide a compelling expla-
nation for how RSV transcription is initiated, they raise the
question: if the gs-like element in the le core promoter positions
the polymerase to initiate opposite nucleotide 3 of the genome,
how does the polymerase initiate replication from position 1? In
considering this, it is helpful to appreciate that replication of a
linear viral genome presents a challenge to a polymerase. The
reason being that RNA synthesis initiation is a complex enzymatic
process, in which the polymerase and template must stabilize and
position the two incoming NTPs sufﬁciently well to allow forma-
tion of the ﬁrst phosphodiester bond. This is even more challen-
ging at the end of a linear template because there is limited RNA
template for the polymerase to associate with. For this reason,
viruses with linear genomes have evolved complex mechanisms of
replication initiation that help provide stability to the initiating
complex (van Dijk et al., 2004). An initiation processes that has
been particularly well characterized is that utilized by phi6
bacteriophage. In this case, the polymerase enters internally on
the template and then ratchets in a 50 to 30 direction to reposition
the active site opposite nucleotide 1 (Butcher et al., 2001). Based
on this model and what is known regarding other RNA viruses, a
logical mechanism for RSV replication initiation would be internal
entry at the promoter element at nt 3–11 followed by events to
enable initiation at position 1. Evidence as to how this might
happen during RSV replication came from studies probing the role
of the ﬁrst nucleotide in determining the replication start site
(Noton et al., 2010). It was found that if the ﬁrst nucleotide of the
tr promoter was mutated, the replication product was restored to
wild type sequence in a single round of replication. These ﬁndings
indicate that when the polymerase initiates RNA replication, it is
able to select the initiating ATP independently of the template.
Similar results were obtained for the RSV le promoter, and in this
case there was evidence that the second nucleotide, a cytidine,
was also selected in a template independent manner (Noton and
Fearns, 2011). Studies with rotavirus and Dengue virus, have
shown that their viral polymerases can self-generate a dinucleo-
tide primer (Chen and Patton, 2000; Selisko et al., 2012). Taken
together, these ﬁndings suggest a replication initiation model in
which the polymerase becomes loaded with the ﬁrst two nucleo-
tides of the replication product, ATP and CTP, independently of the
template and self-generates a primer. It could then bind the core
promoter element, ratchet backwards by one nucleotide to posi-
tion the 50 AC primer opposite nucleotides 1 and 2, and then use
the primer to initiate RNA synthesis. This would give the
Mumps 
(Rubulavirus) 
le UGGUUCCCCUUUU
tr UGGUUCCCCUCUU
N  UUCGGGCCU
P  UCCGGGCCU
M  UUCGUGCUU
F  UUCGGAUCU
SH UUCUUACUU
HN UUCGGUCUU
L  UCCGGUCUU
Measles virus 
(Morbillivirus) 
le UGGUUUGUUUC
tr UGGUCUGUUUC
N  UCCUAAGUUC
P  UCCUUGGUCC
M  UCCUCGUUUC
F  UCCCGGUUCC
H  UCCCACGUUC
L  UCCCAGGUUC
Atlantic salmon paramyxovirus
(Aquaparamyxovirus)
le UGGUUUGUUCUUC
tr UGGUUUGUUCUUC
N  UCCUAGUUUC
P  UCCUAGUUUC
M  UCCUAGUUUC
F  UCCUAGUUUC
HN UCCUAGUUUC
L  UCCUAGUUUC
Newcastle disease virus 
(Avulavirus) 
le UGGUUUGUCUCU
tr UGGUUUGUCUCU
N  UGCCCAUCUU
P  UGCCCAUCUU
M  UGCCCAUCUU
F  UGCCCAUCUU
HN UGCCCAUCUU
L  UGCCCAUCCU
Fer de Lance virus 
(Ferlavirus) 
le UGGGUUGUUCCCCUUUAU
tr UGGGUUGUUCCCCUUUAU
N  UCCUAGUUUC
P  UCCUAGUUUC
M  UCCUUGUUUC
F  UCCUCGUUUC
HN UCCUAGUUUC
L  UCCUAGUUUC
Hendra virus 
(Henipavirus) 
le UGGCUUGUUCCC
tr UGGCUUGUUCCC
N  UCCUUGGUUC
P  UCCUAGGUUC
M  UCCUCUGUCC
F  UCCUCGGUUC
G  UCCUGGGUUC
L  UCCUGGGUUC
Sendai virus 
(Respirovirus) 
le UGGUUUGUUCUC
tr UGGUCUGUUCUC
N  UCCCAGUUUC
P  UCCCACUUUC
M  UCCCACUUUC
F  UCCCUAUUUC
HN UCCCACUUUC
L  UCCCACUUAC
Human metapneumovirus
(Metapneumovirus) 
le UGCGCUUUUUUUG
tr UGCCGUUUUUUUG
N  CCCUGUUCA
P  CCCUGUUCA
M  CCCUGUUCA
F  CCCUGUUUA
M2 CCCUGUUUA
SH CCCUAUUCA
G  CCCUGUUCA
L  CUCUGUUUA
Human RSV 
(Pneumovirus) 
le UGCGCUUUUUU
tr UGCUCUUUUUU
NS1 CCCCGUUUA
NS2 CCCCGUUUA
N   CCCCGUUUA
P   CCCCGUUUA
M   CCCCGUUUA
SH  CCCCGUUUA
G   CCCCGUUUA
F   CCCCGUUUA
M2  CCCCGUUUA
L   CCCUGUUUUA
Fig. 5. Promoter and gs sequences for one virus species from each of the paramyxovirus genera (indicated in parentheses). The gs signals for each of the viral genes are
shown. The promoter sequences shown were deﬁned as those nucleotides that were identical or almost identical between the le and tr promoters; the minimal core
promoters might be more constrained than what is shown. Pyrimidine and purine residues are shown in orange and green type, respectively.
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appearance that replication is initiated from position 1, although
the ﬁrst templated nucleotide insertion would be opposite posi-
tion 3 (Fig. 4B).
There are also data to suggest a mechanism for how the RNA
initiated at position 1 can become encapsidated. Studies performed
in vitro, using puriﬁed, recombinant RSV L-P complexes, have
shown that they initiate RNA synthesis at both position 1 and 3 sites
of the promoter (Noton et al., 2014). Thus, in the case of RSV, N
protein is not required for replication initiation at position 1,
indicating that in infected cells N protein becomes recruited after
initiation of RNA synthesis. This suggests that encapsidation begins
by N binding to a signal at the 50 end of the nascent RNA. In a
minigenome experiment, in which a position 3C-to-U substitution
was introduced into the le promoter to create a promoter sequence:
30 UGUGCUUUU (the 3C-to-U substitution is underlined), a high
level of full-length encapsidated replication product was generated
from position 3 (Noton and Fearns, 2011). This suggests that 50 AC at
the end of the RNA correlates with encapsidation and replication
elongation. Based on these ﬁndings, we propose that when the
polymerase initiates antigenome synthesis at position 1, the nascent
RNA that is synthesized contains cis-acting elements that signal
initiation of encapsidation, with 50 AC playing a key role.
Together, these proposed mechanisms for transcription and
replication initiation integrate to form a cohesive model. The
binding site for the RSV polymerase is located at nt 3–11 of the
le region and RSV L-P complex alone, with no other viral proteins,
is able to interact with this signal to initiate RNA synthesis. Most
frequently, the polymerase initiates directly at position 3. Because
the RNA initiated at this site lacks a complete encapsidation signal,
the polymerase is unable to enter an efﬁcient elongation mode and
generates abortive transcripts. Having released the leþ transcript,
the polymerase can scan forward and locate the gs signal at
position 45 to reinitiate RNA synthesis and become committed
to transcription. Less frequently, the polymerase is able to become
loaded with ATP and CTP and self-generate a primer. When this
happens the polymerase can generate an RNA that is apparently
initiated at position 1, and engage in RNA replication.
Can the RSV transcription and replication initiation model be applied
to other paramyxoviruses?
As described above, paramyxoviruses are divided into the para-
myxovirinae and pneumovirinae. These two sub-families clearly
share many similarities in transcription and replication mechanisms,
but they differ signiﬁcantly in the organization of their promoters.
Therefore, is it reasonable to think that the model proposed for RSV, a
pneumovirus, will apply to other paramyxoviruses?
There are three differences in the organization of the pneumo-
virus and paramyxovirus promoters. First, whereas the RSV pro-
moters are contained entirely within the le or tr regions the
promoters of the paramyxovirinae are bipartite. One promoter
element (promoter element I) lies within approximately the ﬁrst
12 nt of the template (Hoffman and Banerjee, 2000; Marcos et al.,
2005; Mioulet et al., 2001) and is sensitive to mutation at almost all
positions (Hoffman and Banerjee, 2000), similarly to the core
promoter of RSV. The other (promoter element II) lies further
downstream, between nucleotides 79 and 96 of the respiro- and
morbilliviruses and between 77 and 94 of the rubulaviruses, and is
a more simple motif repeated three times, either (CNNNNN)3 or
(NNNNGC)3 (Hoffman and Banerjee, 2000; Marcos et al., 2005;
Mioulet et al., 2001; Murphy et al., 1998; Tapparel et al., 1998;
Walpita, 2004; Walpita and Peters, 2007). Second, the paramyx-
ovirinae promoter elements need to be positioned in the appro-
priate phase relative to N protein and aligned adjacent to each other
on the helical nucleocapsid to be functional (Murphy et al., 1998;
Tapparel et al., 1998; Vulliemoz and Roux, 2001) (see Murphy et al.,
1998, Fig. 8 for an illustration of the promoter alignment on the
nucleocapsid helix). In contrast N phasing has no effect on the
efﬁciency of the RSV promoters (Samal and Collins 1996). Third,
whereas the RSV promoter must lie near the 30 end of the template
to be functional, this is not the case in the paramyxovirinae (Cowton
and Fearns, 2005; Vulliemoz and Roux, 2001, 2002). Together, these
data suggest that the structure that the polymerase recognizes to
form its initial contacts with the promoter is distinct between
pneumo- and paramyxovirinae, with the pneumovirus polymerase
relying, at least in part, on the unique structure that would be
present at the 30 end of the nucleocapsid, and the polymerase of the
paramyxovirinae recognizing promoter bases by virtue of their
positioning within the N-RNA helix. However, having bound the
promoter in the nucleocapsid, it would be expected that the N-RNA
structure would become relaxed at the initiation site to allow the
RNA into the polymerase active site. Thus, in both pneumo- and
paramyxovirinae the next step would be expected to involve a
direct polymerase-RNA interaction.
Aside from this difference in initial promoter recognition, other
aspects of transcription initiation are conserved between pneumo and
paramyxovirinae. Aside from the necessity for promoter element I,
the le sequence prior to the ﬁrst gs signal is not essential for
transcription (Cordey and Roux, 2007; Hoffman et al., 2006;
Vulliemoz et al., 2005). In the paramyxovirinae, the ﬁrst gs signal lies
on the opposite face of the helical nucleocapsid from the promoter
elements, suggesting that it is not seen in conjunction with them (Le
Mercier et al., 2003), and like the RSV gs signal, it can function if it is
placed at varying distances relative to the promoter, although its
natural position is optimal (Hoffman et al., 2006; Vulliemoz et al.,
2005; Fearns et al., 2000; Cordey and Roux, 2006). Finally, it has been
known for a long time that the SeV and MeV polymerases synthesize
a heterogeneous population of abortive transcripts from a site at, or
near, the 30 end of le (Vidal and Kolakofsky, 1989; Leppert et al., 1979;
Horikami and Moyer, 1991). These data are very consistent with what
has been found for RSV, and with a model that the polymerase
initiates transcription from the 30 end of the promoter.
The question that remains is: does the polymerase of the
paramyxovirinae use a gs-like sequence at the 30 end of the le
promoter for initiation, and are transcription and replication initiated
from two different start sites? Fig. 5 shows the 30 terminal promoter
elements (promoter element I) and gs sequences for a representative
virus species of each paramyxovirus genus. The most striking
observation is that while the promoter sequences of the paramyx-
oviridae do not obviously align, all of them begin with 30 UG,
meaning that the replication product is initiated 50 AC. This suggests
that the mechanism that RSV uses to select initiating NTPs to begin
replication is probably conserved throughout the family. On the
other hand, identity between promoter and gs signals is not that
obvious in the paramyxovirus subfamily. However, as noted above,
these signals are multifunctional and differences between them
might be important for determining the fate of the RNA products
(e.g. whether they will be capped, encapsidated, or aborted). Indeed,
we only noticed the identity between RSV promoter and L gs signal
because the 30 terminal le nucleotides required speciﬁcally for
transcription (rather than replication) had been identiﬁed, but this
information is not available for the paramyxovirinae. Thus, the
promoters and gs signals of the paramyxovirinae might contain a
conserved polymerase binding and initiation signal, even if not
readily apparent. With this in mind, a closer inspection of the
sequence alignments suggests that there might be a gs-like signal
in the paramyxovirus promoters. By color coding the pyrimidine and
purine nucleotides, it is apparent that the promoters and gs signals
both contain a motif consisting of a pyrimidine stretch, followed by
1–3 nt of variable sequence that typically contains a purine, followed
by a second pyrimidine stretch. This motif typically aligns slightly
internally on the promoter, although the optimal alignment varies
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between viruses. This observation, coupled with the fact that
apparently all paramyxoviruses begin replication with 50 AC suggests
that the members of the paramyxovirus family share a common
mechanism of replication initiation, in which the polymerase binds
to a pyrimidine-rich motif, slightly internally on the template, and
perhaps self-generates a primer to initiate opposite position 1.
Although the sequence alignments in Fig. 5 suggest that there
may be a gs-like sequence within the promoters of the paramyx-
ovirinae, it is difﬁcult to conclude that their polymerase initiates
transcription internally, in a similar fashion to RSV. A method to
identify initiation sites experimentally is to perform primer exten-
sion analysis on RNA from virus-infected cells. However, to detect
RNA initiated from position 3 of the RSV le promoter, we needed to
use a primer that hybridized very close to the 50 end of the RNA to
detect the short abortive transcripts. We could ﬁnd no evidence in
the literature of a similar analysis for the paramyxovirinae.
Sequence alignment also does not give a clear indication of an
internal initiation site, particularly given that RNA polymerases
typically initiate synthesis with a purine residue and so initiation
opposite position 2 or 3 of the promoter would be unlikely. In the
absence of any data indicating the presence of an internal initiation
site for transcription, it is probably prudent to assume that the
paramyxovirinae differ from the pneumovirinae in terms of the
exact transcription initiation site, and instead initiate both tran-
scription and replication in the same way, opposite the ﬁrst
nucleotide of the le. As described below, the model that the
polymerase of the paramyxovirinae initiates transcription opposite
position 1 is supported by data regarding transcription and replica-
tion regulation, which appears to be slightly different in RSV versus
SeV and measles virus, as described below.
Part 3: regulation of paramyxovirus polymerase activity
Kinetics of paramyxovirus RNA synthesis
Although paramyxoviruses are relatively simple viruses, it would
be expected that they would have evolved mechanisms to regulate
RNA synthesis to maximize use of available templates and avoid
production of non-functional and potentially detrimental RNAs (e.g.
unencapsidated negative sense RNA could hybridize to mRNAs).
Consistent with this idea, studies in which RSV, measles and SeV
RNAs were examined over a single cycle of infection have provided
evidence for temporal control of RNA synthesis (Bermingham and
Collins, 1999; Plumet et al., 2005; Irie et al., 2014). In the case of
measles virus, where quantitative analysis of each RNA species was
performed, it was found that mRNA accumulated in an exponential
fashion from 2 to 24 h post infection, at which point it reached a
plateau. In contrast, genome and antigenome levels remained at a
low level until 12 h post infection, then increased exponentially at
an equivalent rate until 24 h post infection; thereafter, the rate of
replicative RNA accumulation decreased, but the rate of genome
accumulation exceeded that of antigenome (Plumet et al., 2005).
These ﬁndings are essentially similar to those with RSV
(Bermingham and Collins, 1999). The experiments with SeV mea-
sured antigenome and genome RNAs, speciﬁcally. In this case, it was
found that in the initial stages of infection, the ratio of antigenome
to genome RNA increased signiﬁcantly compared to input virus,
reﬂecting very high use of the le promoter and synthesis of positive
sense antigenome RNA, but at later stages, the ratio reversed due to
very active production of genome RNA from the tr promoter (Irie et
al., 2014). These studies indicate that there are at least two points in
which paramyxovirus gene expression and genome replication are
regulated: ﬁrst, between transcription and replication, and second,
between positive and negative sense RNA synthesis from the le and
tr promoters, respectively. The mechanisms by which these two
transitions might be regulated are described below. In addition,
other regulatory mechanisms might come into play to temper RNA
synthesis, to avoid over-stimulation of the innate immune response,
and/or to ready nucleocapsids for packaging (Gander et al., 2011;
Keller and Parks, 2003; Curran et al., 1991; Horikami et al., 1996;
Nishio et al., 2008; Sleeman et al., 2008; Witko et al., 2006).
Transition from mRNA to antigenome synthesis
The factor responsible for “switching on” replication during
paramyxovirus infection is the viral N protein, which is required
to encapsidate the replication product as the RNA is being synthe-
sized (Horikami et al., 1992; Baker and Moyer, 1988). Although the N
protein is required to enable replication of all paramyxoviruses, the
extent to which it regulates a switch between transcription and
replication appears to differ depending on the virus. In experiments
using the RSV minigenome system it was shown that while
increasing the level of N (or N and P) resulted in an increase in
antigenome synthesis, there was no apparent inhibition of tran-
scription, even at very high levels of N protein (Fearns et al., 1997).
The reason why RSV transcription is not affected by N protein
concentration is now clear: the dominant initiation event from the
le promoter is from position 3, not position 1 (Tremaglio et al.,
2013). There is no evidence that any RNA initiated at position 3 can
be elongated into a replication product. This means that transcrip-
tion would always be the dominant initiation event, regardless of
how much N protein is available for encapsidation. However, a
corollary of the RSV transcription/replication model is that if the
polymerase initiates at position 1, but N levels are low, then this
polymerase could abort RNA synthesis after 25 nt and engage in
transcription. This would mean that N protein levels would control
a switch between transcription and replication, but only for the
relatively small proportion of polymerase that happens to initiate at
position 1, not polymerase that initiates at position 3. Thus, in the
case of RSV, rather than thinking of transcription switching to
replication, it is more appropriate to think in terms of transcription
being a constitutive event, and replication being switched on once
N has accumulated, with just a small cost to transcription.
If transcription and replication were both initiated from position
1 of the le promoter by a single pool of polymerase, then these would
be expected to be interchangeable events. This indeed seems to be
the case for at least two of the paramyxovirinae. In experiments
performed in vitro with SeV and in cellulo with measles virus,
increasing the level of N protein led to an increase in replication
and a discernable decrease in transcription (Curran and Kolakofsky,
2008; Plumet et al., 2005). This difference in the effect of N protein on
transcription between RSV, MeV and SeV provides evidence that
different paramyxoviruses might initiate transcription using different
initiation sites.
Transition from positive to negative sense RNA synthesis
As described above, at a late stage of infection there is a transition
from synthesis of positive to negative sense RNA (Bermingham and
Collins, 1999; Plumet et al., 2005; Irie et al., 2014). This transition
ensures accumulation of a high proportion of genome sense nucleo-
capsids for packaging into virus particles (Irie et al., 2008). One
plausible mechanism by which this transition could occur is by
action of a trans-acting protein that is either absent, or at only a low
level in virus particles, but which accumulates over the course of
infection. There does not appear to be a common protein to control
this transition in the paramyxoviruses and consideration of this
provides further evidence of how divergent the paramyxoviruses are.
The protein most likely responsible for regulating a shift from
positive to negative sense RNA synthesis in the pneumovirinae is
the M2-2 protein. M2-2 is expressed from an alternative and
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downstream open reading frame in the M2 gene (Ahmadian et al.,
2000; Collins et al., 1996). If M2-2 is over-expressed, it inhibits all
RNA synthesis (Collins et al., 1996; Cheng et al., 2005; Kitagawa
et al., 2010). However, examination of the kinetics of RNA acc-
umulation in a recombinant RSV containing a deletion of M2-2
suggests the protein speciﬁcally inhibits positive sense RNA
synthesis (Bermingham and Collins, 1999). How M2-2 functions
to accomplish this is not known, but it binds to the L protein
(Kitagawa et al., 2010), and in this and other respects, shares
similarities with a protein encoded by some of the paramyxovir-
inae, the C protein.
A number of viruses within the paramyxovirinae have the
capability to express C protein from an alternative open reading
frame within the P gene (Lamb and Parks, 2007; Lo et al., 2014). The
SeV C protein has been studied extensively. It is a multifunctional
protein, which plays a role in allowing the virus to evade the host
immune response and inhibit apoptosis. However, it also plays an
important role in modulating viral RNA synthesis. If the C protein is
over-expressed it inhibits all RNA synthesis (Cadd et al., 1996;
Tapparel et al., 1997). However, at normal expression levels, the
protein functions in a promoter speciﬁc manner, inhibiting RNA
synthesis from the le promoter, but not from the tr promoter
(Vulliemoz and Roux, 2002; Cadd et al., 1996; Tapparel et al., 1997;
Curran et al., 1992). Indeed, in recent work using recombinant viruses
lacking C protein, it was shown that the le promoter is a stronger
promoter than the tr, contrary to what had been thought previously
(Irie et al., 2014), and that C protein is the key factor that ensures that
genome RNA is more abundant in cells than antigenome (Irie et al.,
2014, 2008). C protein binds to the L subunit of the polymerase and
the strength of this interaction correlates with the ability of C protein
to exert its inhibitory effect (Grogan and Moyer, 2001; Horikami
et al., 1997). Thus, C protein acts directly to modify the polymerase
complex and affect its behavior at the le promoter.
The ferla, avula and rubulavirus genera of the paramyxovirinae
do not express a C protein (Lo et al., 2014) and it is not clear if they
have a functional homolog. However, one possible candidate is their
V protein. The V proteins are multi-functional proteins, expressed
from the same gene that expresses P, by almost all paramyxovirinae.
The V proteins can inhibit RNA replication by binding N protein
(Horikami et al., 1996), but the V proteins of some viruses have also
been shown to bind to L (Nishio et al., 2008; Sweetman et al., 2001).
In the case of PIV-2, a rubula virus, L–V interaction was responsible
for inhibiting RNA synthesis in a minigenome system (Nishio et al.,
2008). Thus, it is possible that V might bind L to fulﬁll a similar
function as C protein in some of the paramyxovirinae.
Finally, another factor that could play a role in regulating the
polymerase between different RNA synthesis activities is P protein
phosphorylation. The P proteins are heavily phosphorylated (as
indicated by their name), but in most cases in which the effect of
phosphorylation status has been examined, there has been either
inconsistent results between in vitro assays and recombinant virus, or
no detectable effect (Barik et al., 1995; Dupuy et al., 1999; Hu and
Gupta 2000; Hu et al., 1999; Lu et al., 2002; Mazumder and Barik,
1994). However, in experiments with the rubulaviruses, PIV5 and
mumps virus, regulatory effects of phosphorylation have been clearly
demonstrated (Pickar et al., 2014; Sun et al., 2009; Timani et al.,
2008). In addition, sumoylation been shown to impact RNA synthesis
(Sun et al., 2011). Given these ﬁndings, it would be interesting to
determine to what extent phosphorylation and other post-transla-
tional modiﬁcations can play a role in temporal regulation.
Can RNA secondary structure in the promoters play a regulatory role?
As described above, it is well established that the genome and
antigenome RNAs of the paramyxoviruses are encapsidated along
their length with N protein at all times of infection. Thus, these
RNAs are not expected to form secondary structures, and cis-acting
signals are comprised entirely of primary sequence. However,
recent work with RSV indicates that the tr promoter might not be
completely encapsidated at all times, suggesting the possibility that
promoter RNA secondary structure could play a regulatory role. It
was found that antigenome sense RNA isolated from RSV infected
cells is heterogeneous, containing one to three nucleotide additions
at the 30 end (Noton et al., 2012). Nucleotide addition was shown to
occur because the tr RNA could adopt a secondary structure that
allowed limited templated nucleotide addition. A similar phenom-
enon has been described for Borna disease virus, another NNS RNA
virus (Martin et al., 2011). In the case of Borna disease virus, the 30
nucleotide addition enables the virus to generate replicative RNA
lacking a 50 triphosphate, allowing it to escape immune surveillance
(Schneider et al., 2005), but this is not the case in RSV and so the
signiﬁcance of the nucleotide addition is not clear. However, it was
found that in the context of a naked RNA template, the three-
nucleotide addition signiﬁcantly inhibited RSV tr promoter activity
(Noton et al., 2012). Thus, one possible explanation for this ﬁnding
is that the capacity for forming a secondary structure and adding
nucleotides onto the tr promoter serves as a mechanism for sensing
available N protein. According to this hypothesis, if N protein levels
are low as the polymerase completes antigenome synthesis, encap-
sidation of the RNA lags behind and there is the opportunity for the
RNA to form a secondary structure and additional nucleotides to be
added onto the 30 end of the tr promoter. In this case, the newly
synthesized antigenome RNA cannot act as a template to produce
genome RNA, and polymerase remains available to reinitiate RNA
synthesis on available genome templates, resulting in increased N
protein expression. On the other hand, if N protein is abundant, the
newly synthesized antigenome RNA is encapsidated as it is synthe-
sized and does not have the opportunity to form a secondary
structure to modify the 30 end of the tr promoter. In this case, the
polymerase can efﬁciently initiate genome RNA synthesis from the
tr promoter. While considerable work is required to test this
hypothesis, the idea that limited RNA secondary structure might
play a role in regulating transcription and replication is intriguing.
The possibility that promoter secondary structure might play a
role in its regulation has also been suggested for SeV (Irie et al., 2014).
This idea emerged from studies to deﬁne the sequence within the le
promoter that is responsible for inhibition by C protein. Swaps
between le and tr promoter sequences failed to identify a speciﬁc
primary sequence that could be responsible (Irie et al., 2014; Tapparel
et al., 1997). However, there was a correlation between lack of
predicted promoter secondary structure and C protein inhibition
(Irie et al., 2014). It is difﬁcult to reconcile the idea that RNA secondary
structure plays a role in SeV given that the bipartite promoter appears
to function by being positioned on the same face of a helical
nucleocapsid. Furthermore, mutation analysis of the PIV-3 promoters
using the minigenome system failed to identify a role for RNA
secondary structure (Hoffman and Banerjee, 2000). However, promo-
ter secondary structures might form as the N-RNA template is relaxed
during polymerase binding and such secondary structure effects
might not be detectable in a minigenome assay due to the excess of
N protein in this system. Therefore, while the data to support the idea
are limited, it is interesting to speculate that perhaps the genome and
antigenome 30 termini are not entirely encapsidated at all times
during infection, and that under certain circumstances, RNA second-
ary structures may play a role in governing promoter activity.
Future directions
In our view, the main gaps in knowledge in paramyxovirus
transcription and replication research fall in two main areas. First, it
will be valuable to have an understanding of how the RNA synthesis
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machinery functions, at a molecular level. While there are structures
for many paramyxovirus proteins, there is relatively little structural
information available regarding the L protein. An exciting develop-
ment in NNS RNA virology in recent years includes establishment of
enzymatic assays using recombinant SeV, VSV, and RSV polymerase
(Noton et al., 2012; Ogino et al., 2005; Morin et al., 2012; Li et al.,
2008; Ogino and Banerjee 2007; Rahmeh et al., 2009). This break-
through has opened up the opportunity to perform detailed mechan-
istic and structural studies of the polymerase complex (Morin et al.,
2013; Rahmeh et al., 2010). The second main area to pursue involves
developing a better appreciation of temporal and perhaps spatial
regulation of polymerase and nucleocapsid function. There is rela-
tively little known about what happens to the paramyxovirus
nucleocapsid and polymerase once they have been delivered into a
cell, or how cellular proteins might alter their structures and func-
tions. The ability to generate recombinant paramyxoviruses, coupled
with developments in high-throughput “omics” approaches and high-
resolution microscopy, has the potential to provide enormous insight
into the interplay between the virus and the host cell. Finally, as we
think this review conveys, a true understanding of paramyxovirus
transcription and replication mechanisms will come from continued
research on a variety of viruses so that we can appreciate the
similarities and differences between them.
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